Figure 3.
Semiquantitative analysis of MT-3 antibody staining in DCIS and invasive breast carcinoma grouped by outcome. The MT-3 staining intensity of DCIS lesions was stronger in patients with bad outcomes than patients with good outcomes.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.